0001798749-20-000001.txt : 20200108 0001798749-20-000001.hdr.sgml : 20200108 20200108151352 ACCESSION NUMBER: 0001798749-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200108 DATE AS OF CHANGE: 20200108 EFFECTIVENESS DATE: 20200108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-357485 FILM NUMBER: 20515562 BUSINESS ADDRESS: STREET 1: C/O RA CAPITAL MANAGEMENT STREET 2: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2494 MAIL ADDRESS: STREET 1: C/O RA CAPITAL MANAGEMENT STREET 2: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001798749 Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 617-778-2494 DELAWARE None None Corporation true 2018 Joshua Resnick Aerovate Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Andrew Levin Aerovate Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Benjamin Dake Aerovate Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Executive Officer James Schneider Aerovate Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Other Technology Decline to Disclose 06b false 2019-12-30 false true true false 0 2500000 2500000 0 false 3 0 0 0 false Aerovate Therapeutics, Inc. Benjamin Dake Benjamin Dake President 2020-01-08